G352 (Fenofibrate 160 mg)

Pill imprint G352 has been identified as Fenofibrate 160 mg.

Fenofibrate is used in the treatment of hypertriglyceridemia; hyperlipoproteinemia; hyperlipoproteinemia type iia, elevated ldl; hyperlipoproteinemia type iv, elevated vldl; hyperlipoproteinemia type iib, elevated ldl vldl (and more), and belongs to the drug class fibric acid derivatives. Risk cannot be ruled out during pregnancy. Fenofibrate 160 mg is not subject to the Controlled Substances Act.

See also related documents.

Imprint Search

Images for G352

Fenofibrate 160 mg G352  Front
Fenofibrate 160 mg G352  Back
Fenofibrate 160 mg G352
Fenofibrate 160 mg G352
Fenofibrate 160 mg G352
Fenofibrate
Imprint:
G352
Strength:
160 mg
Color:
White
Size:
15.00 mm
Shape:
Capsule-shape
Availability:
Prescription only
Drug Class:
Fibric acid derivatives
Pregnancy Category:
C - Risk cannot be ruled out
CSA Schedule:
N - Not a controlled drug
Manufacturer:
Global Pharmaceuticals
National Drug Code (NDC):
00115-5522
Inactive Ingredients:
croscarmellose sodium
hypromelloses
magnesium stearate
microcrystalline cellulose
hypromellose 2910 (3 mPa.s)
hypromellose 2910 (6 mPa.s)
hypromellose 2910 (50 mPa.s)
polyethylene glycol
polydextrose
titanium dioxide
triacetin
Other Manufacturers / Repackagers:
NDC CodeManufacturer / Repackager
68084-0328 Amerisource Health Services

Note: Inactive ingredients may vary.

View Details Print Page

Disclaimer: Every effort has been made to ensure that the information provided is accurate, up-to-date, and complete, but no guarantee is made to that effect. If you have questions about the drugs you are taking, check with your doctor, nurse or pharmacist.

Copyright 2014 Drugs.com, National Library of Medicine, Truven Health Analytics and Cerner Multum, Inc. All Rights Reserved.

Hide
(web5)